Cognitive function in the sleep apnea/hypopnea syndrome (SAHS)

Area of Science:

• Neurology
• Sleep Medicine
• Cognitive Neuroscience

Background:

• Sleep apnea/hypopnea syndrome (SAHS) is linked to cognitive deficits.
• Understanding the extent, causes, and reversibility of these deficits is crucial for clinical management and research.
• Existing studies suggest varying degrees of impairment across different cognitive domains.

Purpose of the Study:

• To quantitatively assess the magnitude of cognitive deficits in SAHS.
• To identify determinants of cognitive outcomes in SAHS patients.
• To evaluate the reversibility of cognitive deficits with CPAP treatment.

Main Methods:

• A meta-analysis of case-control studies was used to determine effect sizes of cognitive impairment in SAHS.
• A study of 150 SAHS patients analyzed correlations between cognitive scores and disease severity metrics (AHI, oxygen saturation).
• A meta-analysis of randomized placebo-controlled crossover trials assessed the impact of CPAP on cognitive function.

Main Results:

• Significant cognitive deficits were observed in SAHS, with large effect sizes for attention (approx. 1.0 SD) and executive functions (approx. 0.9 SD), and moderate for memory (approx. 0.6 SD).
• Disease severity (AHI, minimum oxygen saturation) showed weak associations with cognitive performance.
• CPAP treatment demonstrated small effect sizes (approx. 0.2 SD) for cognitive enhancement, with trends towards improvement.

Conclusions:

• Cognitive deficits in SAHS are substantial and worsen with disease severity.
• Sleepiness and hypoxemia may contribute to cognitive impairment.
• While CPAP may offer some cognitive benefits, the small effect sizes suggest potential irreversibility or factors limiting treatment efficacy.